TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32056459

Group type: EXPERIMENTAL
Intervention: Randomized double-blind controlled trials (RDB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-randomized double-blind trials
Number of subjects: 24
Study: 34237210

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with temozolomide followed by 6 cycles of adjuvant temozolomide (arm A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone (arm B)
Number of subjects: 90
Study: 34162789

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai chi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0
Study: 33622986

Group type: EXPERIMENTAL
Intervention: SKA‐4
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐21
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐1, SKA‐4, SKA‐6, SKA‐17
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐11, SKA‐17
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐19
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐6, SKA‐21, SKA‐27, AWS‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SKA‐17
Number of subjects: 16
Study: 34784592

Group type: EXPERIMENTAL
Intervention: High-frequency yoga breathing
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Alternate nostril yoga breathing
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bellows yoga breathing
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bumblebee yoga breathing
Number of subjects: 38
Study: 33689919

Group type: EXPERIMENTAL
Intervention: Proposed sample size method for matched-pair cluster randomization design with continuous outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bias-corrected variance estimators
Number of subjects: 0
Study: 35246214

Group type: EXPERIMENTAL
Intervention: Opioid-sparing therapies
Number of subjects: 42

Group type: COMPARATOR
Intervention: Opioid-based therapies
Number of subjects: 42
Study: 32068667

Group type: EXPERIMENTAL
Intervention: Low concentration desipramine titrated to reach a serum concentration level of 15 to 65 ng/mL
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and active placebo medication (benztropine mesylate, 0.125 mg)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Low concentration desipramine and CBT
Number of subjects: 142

Group type: COMPARATOR
Intervention: Active benztropine placebo medication
Number of subjects: 142
Study: 33734127

Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac sodium (1.5 mg/kg)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous paracetamol (15 mg/kg)
Number of subjects: 110
Study: 33047618

Group type: EXPERIMENTAL
Intervention: Assessment of hemoglobin levels using cyanmethaemoglobin method
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Socio-demographic and health status factors
Number of subjects: 32
Study: 32212810

Group type: EXPERIMENTAL
Intervention: 30 mg/m2 cisplatin weekly (Arm A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 100 mg/m2 cisplatin once every 3 weeks (Arm B)
Number of subjects: 60
Study: 35720170

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) 115 ml daily for 7 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Green leafy vegetable juice 250 ml daily for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison between BRJ and green leafy vegetable juice
Number of subjects: 18
Study: 32950343

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Triamcinolone
Number of subjects: 110
Study: 32763279

Group type: EXPERIMENTAL
Intervention: Maternal BPA exposure
Number of subjects: 96
Study: 36427271

Group type: EXPERIMENTAL
Intervention: Immobilization (IM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Maximal eccentric exercise (MaxEC) after immobilization
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 33419902

Group type: EXPERIMENTAL
Intervention: Dysuria in women aged 15-29
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Dysuria in women aged 30-44
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Symptoms combined for post-test probabilities
Number of subjects: 1178
Study: 36309483

Group type: EXPERIMENTAL
Intervention: Vortioxetine treatment
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1362

Group type: EXPERIMENTAL
Intervention: Self-reported response in vortioxetine-treated patients
Number of subjects: 1362
Study: 34136570

Group type: EXPERIMENTAL
Intervention: Endoscopic bag during laparoscopic morcellation
Number of subjects: 48

Group type: COMPARATOR
Intervention: No bag during laparoscopic morcellation
Number of subjects: 48
Study: 35944570

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.25%
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.3%
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 90
Study: 34765324

Group type: EXPERIMENTAL
Intervention: Personalized lifestyle recommendations
Number of subjects: 25

Group type: COMPARATOR
Intervention: No recommendations (Control)
Number of subjects: 25
Study: 35980237

Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid + adhesive (HFS-A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Hydrofluoric acid (HFS) without adhesive
Number of subjects: 96

Group type: COMPARATOR
Intervention: Self-etching primer (MEP)
Number of subjects: 96
Study: 32044511

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC) using anthracycline-based regimen without taxanes
Number of subjects: 30
Study: 34478006

Group type: EXPERIMENTAL
Intervention: Live Z-score Neurofeedback (LZS)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Slow Cortical Potential (SCP)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Working-memory training (WMT)
Number of subjects: 202
Study: 32895960

Group type: EXPERIMENTAL
Intervention: Early recurrence (ER) after pulmonary vein isolation (PVI)
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: Reablation subgroup
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: Early recurrence (ER) timing
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: ROC analysis for 14-day blanking period
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: ROC analysis for 30-day blanking period
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: Patients with diabetes
Number of subjects: 1285
Study: 36958105

Group type: EXPERIMENTAL
Intervention: UVC dwell-time of 8-14 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: UVC dwell-time of 1-7 days (control group)
Number of subjects: 63
Study: 33389369

Group type: EXPERIMENTAL
Intervention: topical timolol 0.5% (n = 16)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: topical brimonidin (n = 15)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: oral acetazolamide 250 mg (n = 14)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: intravenous mannitol (1.5 gr/kg) (n = 16)
Number of subjects: 74

Group type: COMPARATOR
Intervention: no intraocular pressure-lowering medication (n = 13)
Number of subjects: 74
Study: 33174383

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) 3 times weekly for 8 weeks
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) 3 times weekly for 8 weeks
Number of subjects: 442

Group type: COMPARATOR
Intervention: Sham acupuncture (SA) 3 times weekly for 8 weeks
Number of subjects: 442

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) vs Sham acupuncture (SA)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Manual acupuncture (MA) vs Sham acupuncture (SA)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) and Manual acupuncture (MA)
Number of subjects: 442
Study: 33351101

Group type: EXPERIMENTAL
Intervention: VKA regimen with triple-Antithrombotic therapy
Number of subjects: 0
Study: 32706640

Group type: EXPERIMENTAL
Intervention: Postradiation chemotherapy (PCV; procarbazine, lomustine (CCNU), and vincristine)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Radiation alone (Control)
Number of subjects: 106
Study: 35751032

Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed once daily (n=9)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed twice daily (n=10)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed thrice daily (n=9)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual-activity control (n=10)
Number of subjects: 38
Study: 36364828

Group type: EXPERIMENTAL
Intervention: Food for special medical purposes composed of omega‐3 fatty acids (500 mg), leucine (2.5 g), and probiotic Lactobacillus paracasei PS23
Number of subjects: 60
Study: 33332480

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study: 34224508

Group type: COMPARATOR
Intervention: Active Stretching (AS)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) + Active Stretching (AS)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) + Active Stretching (AS)
Number of subjects: 135
Study: 32769437

Group type: EXPERIMENTAL
Intervention: Noise reduction algorithms and directional microphones activated
Number of subjects: 47

Group type: COMPARATOR
Intervention: Noise reduction algorithms and directional microphones deactivated
Number of subjects: 47
Study: 33064051

Group type: EXPERIMENTAL
Intervention: Cascading classifier approach for TMB topology prediction; two-layers cascading classifier used.
Number of subjects: 0
Study: 34587662

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education and exercise (6-month plan created by a physical therapist)
Number of subjects: 104

Group type: COMPARATOR
Intervention: General feedback after questionnaire (Control)
Number of subjects: 104
Study: 35126899

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (supplemented with Western medical treatment)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Yuebi Jiazhu Tang (subgroup analysis)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Ganlu Xiaodu Dan (subgroup analysis)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Yupingfeng granules (subgroup analysis)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Conventional Western medical treatment
Number of subjects: 455
Study: 33859084

Group type: EXPERIMENTAL
Intervention: Corneal neurotization (CN) - both direct and indirect approaches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corneal neurotization (CN)
Number of subjects: 0
Study: 32678434

Group type: EXPERIMENTAL
Intervention: 12 mg iron micronutrient powder given in the morning
Number of subjects: 65

Group type: COMPARATOR
Intervention: 12 mg iron micronutrient powder given in the afternoon
Number of subjects: 65

Group type: COMPARATOR
Intervention: Consecutive day dosing of 12 mg iron
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Alternate day dosing of 12 mg iron
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Baseline dose of 12 mg iron
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Every third day dosing of 12 mg iron
Number of subjects: 65
Study: 35132421

Group type: EXPERIMENTAL
Intervention: Oral camostat mesylate, 200 mg po four times a day for 7 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 34315440

Group type: EXPERIMENTAL
Intervention: High cognitive leisure activities (CLAs) engagement and high long-chain polyunsaturated fatty acids (LCPUFAs) intake
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Art appreciation as a cognitive leisure activity
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Major LCPUFAs (docosahexaenoic acid and arachidonic acid)
Number of subjects: 517
Study: 34174224

Group type: EXPERIMENTAL
Intervention: Group wheelchair maintenance training (two 90-minute classes)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Waitlist control group (WLCG)
Number of subjects: 147
Study: 32406224

Group type: EXPERIMENTAL
Intervention: Single rehabilitative treatment (ST)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Group rehabilitative treatment (GT)
Number of subjects: 63
Study: 36202162

Group type: EXPERIMENTAL
Intervention: Pressure level 30
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pressure level 20
Number of subjects: 120
Study: 33170444

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 individual, weekly sessions preoperative
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0
Study: 33370549

Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Circuit Resistance Training (CRT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Interval Resistance Training (IRT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 44
Study: 33556230

Group type: EXPERIMENTAL
Intervention: Atezolizumab and bevacizumab combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study: 32280004

Group type: EXPERIMENTAL
Intervention: Response surface methodology (RSM) optimization for biomass production
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimum conditions established by RSM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biomass produced
Number of subjects: 0
Study: 36380312

Group type: EXPERIMENTAL
Intervention: MEDI3902 1500 mg (single intravenous dose)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: MEDI3902 1500 mg
Number of subjects: 188
Study: 33076904

Group type: EXPERIMENTAL
Intervention: Bengali version of the Lequesne Algofunctional index (LAI)
Number of subjects: 130
Study: 36273738

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (20 fractions of 20 Gy)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Conventional radiotherapy (30 fractions of 60 Gy)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy
Number of subjects: 133

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: RapidPlan left hippocampus sparing model
Number of subjects: 133
Study: 33185976

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Physical models
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: VR familiarization phase
Number of subjects: 78
Study: 33780735

Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV)
Number of subjects: 766
Study: 33626005

Group type: EXPERIMENTAL
Intervention: Live Donor Assessment Tool (LDAT)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Clinical evaluation as usual
Number of subjects: 132
Study: 36173726

Group type: EXPERIMENTAL
Intervention: Minimally-invasive envelope flap
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional envelope flap
Number of subjects: 60
Study: 34220324

Group type: EXPERIMENTAL
Intervention: Low bilirubin group (serum bilirubin≤9.7umol/L, n=753)
Number of subjects: 1492

Group type: COMPARATOR
Intervention: High bilirubin group (serum bilirubin>9.7umol/L, n=739)
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Low bilirubin group after PSM (n=566)
Number of subjects: 1492

Group type: COMPARATOR
Intervention: High bilirubin group after PSM (n=566)
Number of subjects: 1492
Study: 32709657

Group type: EXPERIMENTAL
Intervention: Individualised, pharmacist led support service focusing on medication adherence and physical comorbidity management.
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard care (MedsCheck) provided by pharmacists without additional training.
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Individualised, pharmacist led support service.
Number of subjects: 190
Study: 33407022

Group type: EXPERIMENTAL
Intervention: Active recess program (EG) - physical exercise at moderate to vigorous intensity with cognitive engagement for 10 weeks, three times a week
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 114
Study: 35592991

Group type: EXPERIMENTAL
Intervention: Online therapy management system (TMS) with wearable auricular vagus nerve stimulation device
Number of subjects: 0
Study: 34708788

Group type: EXPERIMENTAL
Intervention: Preoperative bevacizumab (BVZ)
Number of subjects: 217

Group type: COMPARATOR
Intervention: No preoperative bevacizumab (BVZ)
Number of subjects: 217
Study: 33040814

Group type: EXPERIMENTAL
Intervention: Physiological seawater nasal irrigation combined with oral desloratadine citrate disodium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral desloratadine citrate disodium
Number of subjects: 100
Study: 35212308

Group type: EXPERIMENTAL
Intervention: Early complementary acupuncture (once a day for 28 days, starting within 72 hours after injury)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 33599087

Group type: EXPERIMENTAL
Intervention: Adapted Dialectical Behaviour Therapy (aDBT-ID)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 20
Study: 32899022

Group type: EXPERIMENTAL
Intervention: Active treatment arm (vitamin K2 isoform 360 mcg 3 times weekly for 18 months)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 200
Study: 35720174

Group type: EXPERIMENTAL
Intervention: Individualised, family-based lifestyle intervention
Number of subjects: 504
Study: 35030386

Group type: EXPERIMENTAL
Intervention: Tier 2 interventions in preschool
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Self-regulation (indexed by executive function and teacher‐rated attention)
Number of subjects: 184
Study: 33922866

Group type: EXPERIMENTAL
Intervention: EMG‐BF‐guided isometric exercise training with patellar taping
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham EMG‐BF training with isometric exercise program
Number of subjects: 60
Study: 32985288

Group type: EXPERIMENTAL
Intervention: Chamomile gel (8.35%)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Urea cream
Number of subjects: 48
Study: 35125276

Group type: EXPERIMENTAL
Intervention: i-PVR group
Number of subjects: 40

Group type: COMPARATOR
Intervention: ni-PVR group
Number of subjects: 40
Study: 36319967

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting hyperkalemia
Number of subjects: 401
Study: 33882021

Group type: EXPERIMENTAL
Intervention: Digital behavior change intervention promoting exercise and ocular relaxation with live streaming and peer sharing of activities
Number of subjects: 954

Group type: COMPARATOR
Intervention: Health education information only (control)
Number of subjects: 954
Study: 35583995

Group type: EXPERIMENTAL
Intervention: Creative arts intervention (60 minutes a day, 3 to 4 days a week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study: 32926847

Group type: EXPERIMENTAL
Intervention: Text parsing tool for identifying poor medication adherence
Number of subjects: 736

Group type: COMPARATOR
Intervention: Self-reported medication adherence assessment
Number of subjects: 736

Group type: COMPARATOR
Intervention: EHR documentation of poor adherence
Number of subjects: 736
Study: 35192860

Group type: COMPARATOR
Intervention: 75-mg clopidogrel daily (n=80)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 3.75-mg prasugrel daily (n=84)
Number of subjects: 164
Study: 33925704

Group type: EXPERIMENTAL
Intervention: Cooked ham enriched with antioxidants (100 g/d)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 32097140

Group type: EXPERIMENTAL
Intervention: Task-orientated rehabilitation program (ToRP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Home-based therapeutic strategies program (Control)
Number of subjects: 93
Study: 36240100

Group type: EXPERIMENTAL
Intervention: Telestroke
Number of subjects: 76

Group type: COMPARATOR
Intervention: PASTA
Number of subjects: 76
Study: 33691439

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dyclonine hydrochloride mucilage
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined treatment (EA + dyclonine hydrochloride)
Number of subjects: 150
Study: 35549750

Group type: EXPERIMENTAL
Intervention: Standard dressings with Mastisol liquid adhesive (MLA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard dressings (control)
Number of subjects: 160
Study: 33798487

Group type: EXPERIMENTAL
Intervention: 2 mg of moxidectin
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 4 mg of moxidectin
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 6 mg of moxidectin
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 8 mg of moxidectin
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 10 mg of moxidectin
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 12 mg of moxidectin
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 35956073

Group type: EXPERIMENTAL
Intervention: 0.4% hyaluronic acid and 0.2% galacto‐xyloglucan (HA-GX)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Hyaluronic acid alone (HA)
Number of subjects: 34
Study: 33132077

Group type: EXPERIMENTAL
Intervention: OCTAID (online tool for diagnosis of macular lesions)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control intervention (standard OCT educational material)
Number of subjects: 118
Study: 32859183

Group type: EXPERIMENTAL
Intervention: Exercise combined with whole body vibration (vertical, 40 Hz, amplitude 2-4 mm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (exercise without vibration)
Number of subjects: 50
Study: 35689370

Group type: EXPERIMENTAL
Intervention: Focused Extracorporeal Shock Wave Therapy (fESWT) at the lumbar and sacral spine (0.15 mJ/mm², 1000 pulses, 4 Hz)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham fESWT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (fESWT and sham) with stabilization training (45 minutes, once a day, 5 days a week)
Number of subjects: 40